Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

713 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
N-Sulfonyl-aminobiaryls as Antitubulin Agents and Inhibitors of Signal Transducers and Activators of Transcription 3 (STAT3) Signaling.
Lai MJ, Lee HY, Chuang HY, Chang LH, Tsai AC, Chen MC, Huang HL, Wu YW, Teng CM, Pan SL, Liu YM, Mehndiratta S, Liou JP. Lai MJ, et al. Among authors: Wu YW. J Med Chem. 2015 Aug 27;58(16):6549-58. doi: 10.1021/acs.jmedchem.5b00659. Epub 2015 Aug 13. J Med Chem. 2015. PMID: 26241032
1-Aroylindoline-hydroxamic acids as anticancer agents, inhibitors of HSP90 and HDAC.
Ojha R, Huang HL, HuangFu WC, Wu YW, Nepali K, Lai MJ, Su CJ, Sung TY, Chen YL, Pan SL, Liou JP. Ojha R, et al. Among authors: Wu YW. Eur J Med Chem. 2018 Apr 25;150:667-677. doi: 10.1016/j.ejmech.2018.03.006. Epub 2018 Mar 5. Eur J Med Chem. 2018. PMID: 29567459
N-alkyl-hydroxybenzoyl anilide hydroxamates as dual inhibitors of HDAC and HSP90, downregulating IFN-γ induced PD-L1 expression.
Mehndiratta S, Lin MH, Wu YW, Chen CH, Wu TY, Chuang KH, Chao MW, Chen YY, Pan SL, Chen MC, Liou JP. Mehndiratta S, et al. Among authors: Wu YW, Wu TY. Eur J Med Chem. 2020 Jan 1;185:111725. doi: 10.1016/j.ejmech.2019.111725. Epub 2019 Sep 24. Eur J Med Chem. 2020. PMID: 31655430
713 results
Jump to page
Feedback